MedPath

The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction

Not Applicable
Completed
Conditions
Erectile Dysfunction
Interventions
Procedure: Li-ESWT
Registration Number
NCT05043896
Lead Sponsor
Dr. Soetomo General Hospital
Brief Summary

to compare the effect of combination of li-eswt and pde-5 inhibitor to pde-5 alone in erectile dysfunction patients

Detailed Description

Comparing the effect of Combination therapy (Li-ESWT combined with PDE5-inhibitor) vs SIngle therapy (PDE5-inhibitor) in mild to moderate Erectile Dysfunction patients.

Parameters used for comparation are EHS score, IIEF-5 score, VEGF level and PSV

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Mild to Moderate Erectile dysfunction
  • Married
  • Sexually active
  • Consenting to participate in the trial
Exclusion Criteria
  • Psychological problems
  • Spinal injury
  • History of malignancy
  • Penile anatomy abnormalities
  • Allergic and Contraindications to tadalafil
  • On anti-mitotic drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Combination therapyTadalafil 2.5Mg TabLi-ESWT + tadalafil
Combination therapyLi-ESWTLi-ESWT + tadalafil
Single TherapyTadalafil 2.5Mg Tabtadalafil only
Primary Outcome Measures
NameTimeMethod
Erectile Hardness Score (EHS)4 weeks

Developed in 1998, the EHS is a single-item Likert scale that men can use on their own.

The tool asks them to consider the question "How would you rate the hardness of your erection?" and select one of the following options:

0 Penis does not enlarge

1. Penis is larger, but not hard

2. Penis is hard, but not hard enough for penetration

3. Penis is hard enough for penetration, but not completely hard

4. Penis is completely hard and fully rigid

The EHS score was taken pre and post intervention

International Index of Erectile Function (IIEF-5) score4 weeks

IIEF-5 is a tool for ED (Erectile Dysfunction)diagnosis. The possible scores for the IIEF-5 range from 5 to 25, and ED was classified into five categories based on the scores: severe (5-7), moderate (8-11), mild to moderate (12-16), mild (17-21), and no ED (22-25)

IIEF-5 score was taken pre and post intervention

Peak Systolic Velocity (PSV)4 weeks

PSV was measured in cm/s, by using Doppler Ultrasonography. The probe is located at the penis, to be precise in the penoscrotal junction, to measure the velocity of the blood flow in the cavernous arteries.

The test was done in flaccid state of the penis Measurement was taken by an experienced ultrasonographer in the radiology unit. Measurement was taken pre and post intervention

Vascular Endothelial Growth Factor (VEGF) level in plasma4 weeks

VEGF was measured in pg/ml. VEGF test were done by blood test in the laboratory using the VEGF-A ELISA Kit.

Blood for tests were drawn pre and post test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

dr. Soetomo General Hospital

🇮🇩

Surabaya, Jawa Timur, Indonesia

© Copyright 2025. All Rights Reserved by MedPath